AU2003289990A1 - Expression of peptides of the cytoplasmic domain of hiv-gp41 for inhibiting viral infections - Google Patents
Expression of peptides of the cytoplasmic domain of hiv-gp41 for inhibiting viral infectionsInfo
- Publication number
- AU2003289990A1 AU2003289990A1 AU2003289990A AU2003289990A AU2003289990A1 AU 2003289990 A1 AU2003289990 A1 AU 2003289990A1 AU 2003289990 A AU2003289990 A AU 2003289990A AU 2003289990 A AU2003289990 A AU 2003289990A AU 2003289990 A1 AU2003289990 A1 AU 2003289990A1
- Authority
- AU
- Australia
- Prior art keywords
- hiv
- peptides
- expression
- viral infections
- cytoplasmic domain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/03—Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16041—Use of virus, viral particle or viral elements as a vector
- C12N2740/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10257770.6 | 2002-12-10 | ||
DE10257770A DE10257770A1 (en) | 2002-12-10 | 2002-12-10 | Expression of peptides in the cytoplasmic region of HIV-gp41 to inhibit viral infections |
PCT/EP2003/013939 WO2004052924A1 (en) | 2002-12-10 | 2003-12-09 | Expression of peptides of the cytoplasmic domain of hiv-gp41 for inhibiting viral infections |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003289990A1 true AU2003289990A1 (en) | 2004-06-30 |
Family
ID=32477538
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003289990A Abandoned AU2003289990A1 (en) | 2002-12-10 | 2003-12-09 | Expression of peptides of the cytoplasmic domain of hiv-gp41 for inhibiting viral infections |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2003289990A1 (en) |
DE (1) | DE10257770A1 (en) |
WO (1) | WO2004052924A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2309269B1 (en) * | 2004-09-08 | 2016-10-26 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Compositions and methods for the detection of HIV-1/HIV-2 infection. |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08503704A (en) * | 1992-11-23 | 1996-04-23 | プレジデント アンド フェロウズ オブ ハーバード カレッジ | GP41 variants and their use as HIV therapeutics |
DE19957838C2 (en) * | 1999-11-25 | 2002-11-21 | Pette Heinrich Inst | Gene therapy of HIV-infected people through expression of membrane-anchored gp41 peptides |
-
2002
- 2002-12-10 DE DE10257770A patent/DE10257770A1/en not_active Ceased
-
2003
- 2003-12-09 AU AU2003289990A patent/AU2003289990A1/en not_active Abandoned
- 2003-12-09 WO PCT/EP2003/013939 patent/WO2004052924A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
DE10257770A1 (en) | 2004-07-08 |
WO2004052924A1 (en) | 2004-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003238456A1 (en) | Viral vector | |
AU2003297547A1 (en) | Tandem tetramerisation-polymerisation of olefins | |
AU2003221824A1 (en) | Barge-mounted tidal-powered desalinization system | |
AU2003268165A1 (en) | Transit system | |
AU2003299718A1 (en) | Velocity enhancement for ofdm systems | |
AU2003256364A1 (en) | Break away fastening system | |
PL376454A1 (en) | 1-acyl-pyrrolidine derivatives for the treatment of viral infections | |
AU2003235284A1 (en) | Perfect airtight-type cage system for protecting transition of pathogen | |
AU2003238767A1 (en) | Dot-elisa for the detection of animal viruses | |
AU2003217991A1 (en) | Hardware implementation of the secure hash standard | |
AU2003290563A1 (en) | Leptin-related peptides | |
AU2003901876A0 (en) | Viral vector | |
AU2003291886A1 (en) | Thiophenederivatives for the treatment of flavivirus infections | |
AU2003234925A1 (en) | TGF-Alpha EXPRESSION INHIBITORS | |
EP1572950A3 (en) | Single domain tdf-related compounds and analogs thereof | |
AU2003206367A1 (en) | Technical field of the invention | |
AU2003257637A1 (en) | Proline derivatives | |
AU2003206510A1 (en) | Gazeification de dechets par plasma | |
AU2003225394A1 (en) | Necktie wearing-device | |
AU2002950473A0 (en) | Expression system | |
AU2003205623A1 (en) | Prion protein carrier-conjugates | |
AU2003289990A1 (en) | Expression of peptides of the cytoplasmic domain of hiv-gp41 for inhibiting viral infections | |
AU2003280896A1 (en) | Detection of demyelination | |
AU2003246091A1 (en) | Mkk7 activation inhibitor | |
AU2003262638A1 (en) | Biotinylation of proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |